Vizient Quality and Accountability Ranking. Ranked #1 out of 115 participating comprehensive academic medical centers." ...
22h
Corbus Pharmaceuticals presented Phase 1 data on CRB-701 at ASCO GU, showing safety, tolerability, and responses across multiple tumor types.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback